These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5307271)

  • 41. Studies on the anticoagulant action of aprotinin ("trasylol").
    Prentice CR; Mcnicol GP; Macnicol GP; Douglas AS
    Thromb Diath Haemorrh; 1970 Oct; 24(1):265-72. PubMed ID: 5312434
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of fibrin proteolysis inhibitors on the level of fibrinogen and the activity of antithrombin VI in citrated stored blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1966; 4(4):455-60. PubMed ID: 5297525
    [No Abstract]   [Full Text] [Related]  

  • 43. [The anticoagulant system following intravenous administration of factor XIII and thromboplastin].
    Liapina LA; Ul'ianov AM; Zhitnikova ES
    Fiziol Zh SSSR Im I M Sechenova; 1976 Aug; 62(8):1166-70. PubMed ID: 992139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo effect of reptilase on fibrinogen metabolism in dogs.
    Egberg N; Nordström S
    Scand J Clin Lab Invest; 1969 Dec; 24(4):383-5. PubMed ID: 5309883
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in the blood coagulation in dogs following intravenous injection of thromboplastin].
    Rusakova GP
    Patol Fiziol Eksp Ter; 1965; 9(5):82-4. PubMed ID: 5877806
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effects of epsilon-aminocaproic acid, amben and kontrikal on fibrinolysis due to tissue-type plasminogen activator from the pig heart].
    Shimonaeva EE; Andreenko GV; Alieva NI
    Farmakol Toksikol; 1986; 49(4):35-8. PubMed ID: 2428660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Electron microscope studies of thrombocytes of rabbits before and after administration of epsilon-aminocaproic acid].
    Beznosikova VK; Chaplygina ZA; Beznosikov BO
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):32-7. PubMed ID: 5736821
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative assessment of the effect of donor blood and its components on the blood coagulation system of the recipient].
    Chistiakov VA; Belitskaia GA
    Vrach Delo; 1966 Jul; 7():39-41. PubMed ID: 5990715
    [No Abstract]   [Full Text] [Related]  

  • 50. Paradoxic changes in platelets and fibrinogen in chronically induced intravascular coagulation.
    Cooper HA; Bowie EJ; Didisheim P; Owen CA
    Mayo Clin Proc; 1971 Aug; 46(8):521-3. PubMed ID: 5566135
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B
    Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comparative effectiveness of epsilon-aminocaproic acid and contrical in preventing complement activation on immune complexes].
    Tsibul'kin AP; Raĭzman SM
    Farmakol Toksikol; 1981; 44(3):316-9. PubMed ID: 6169545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 54. Thromboplastin-induced hypercoagulability and its prevention.
    Nordström S; Olsson P; Blombäck M
    Nature; 1965 May; 206(984):632-3. PubMed ID: 5294395
    [No Abstract]   [Full Text] [Related]  

  • 55. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

  • 56. [Inhibition of the thromboplastic activity of amniotic fluid with Trasylol].
    Slunsky R
    Gynakol Rundsch; 1973; 13(2):147-52. PubMed ID: 4542664
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inhibition of the thromboplastic effect of placental extracts using trasylol].
    Slunsky R
    Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438
    [No Abstract]   [Full Text] [Related]  

  • 58. Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances.
    Gibelli A; Turazza G; Giarola P; De Nicola P
    Farmaco Sci; 1966 Apr; 21(4):301-9. PubMed ID: 4160699
    [No Abstract]   [Full Text] [Related]  

  • 59. The influence of Yoshida sarcoma, -aminocaproic acid and sintrom on the blood clotting system in rats.
    Kotschy M; Grzebieluch M; Szacki J; Lawiñski M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):515-22. PubMed ID: 5095070
    [No Abstract]   [Full Text] [Related]  

  • 60. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.